首页> 外文期刊>The journal of clinical hypertension. >Lifestyle Educational Program Strongly Increases Compliance to Nonpharmacologic Intervention in Hypertensive Patients: A 2-Year Follow-Up Study
【24h】

Lifestyle Educational Program Strongly Increases Compliance to Nonpharmacologic Intervention in Hypertensive Patients: A 2-Year Follow-Up Study

机译:生活方式教育计划大力提高了对高血压患者非药物干预的依从性:一项为期2年的随访研究

获取原文
获取原文并翻译 | 示例
           

摘要

The authors investigated the efficacy of a lifestyle educational program, organized in small group meetings, in improving the outcome of a nonpharmacologic intervention. One hundred and eighty-eight hypertensive patients with stable blood pressure (BP) levels and drug therapy in the previous 6months were randomly divided into educational care (EC) and usual care (UC) groups. They were followed at 3-month intervals up to 2years. In addition to the visits in an outpatient clinic, patients in the EC program participated in small group meetings in order to improve their knowledge of the disease and reinforce their motivation for treatment. At baseline, EC and UC groups were similar for age, sex, body mass index (BMI), blood pressure (BP) levels, and pharmacologic treatment. Patients in the EC group had significantly reduced total energy, total and saturated fats, and sodium intake. Physical activity was significantly increased in the EC group as well. At the end of the 1-year follow-up, BMI (P<.001), visceral fat (P<.001), and BP (P<.001) were significantly lower in the EC group compared with the UC group. Pharmacologic treatment during the study was similar for all classes of drugs apart from diuretics whose dose was higher in the UC group at the end of the study.
机译:作者研究了在小组会议中组织的生活方式教育计划在改善非药物干预效果方面的功效。在前六个月中,将具有稳定血压(BP)水平和药物治疗的188位高血压患者随机分为教育护理(EC)和常规护理(UC)组。他们每3个月进行一次随访,直至2年。除了在门诊就诊外,参加EC计划的患者还参加了小组会议,以提高他们对疾病的认识并增强治疗动机。在基线时,EC和UC组在年龄,性别,体重指数(BMI),血压(BP)水平和药物治疗方面相似。 EC组患者的总能量,总和饱和脂肪以及钠摄入量显着降低。 EC组的体育活动也显着增加。在1年随访期结束时,与UC组相比,EC组的BMI(P <.001),内脏脂肪(P <.001)和BP(P <.001)显着降低。除利尿剂外,所有类别的药物在研究期间的药理治疗均相似,在研究结束时,UC组的剂量较高。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号